Literature DB >> 21676435

Association between natural killer cells and regression in melanocytic lesions.

Kristopher McKay1, Page C Moore, Bruce R Smoller, Kim M Hiatt.   

Abstract

Mortality from melanoma, the deadliest of skin cancers, continues to increase in all age groups. A small number of melanomas spontaneously regress. In vitro studies suggest a role for the natural killer cell in effecting regression. In this study, the goal was to determine if natural killer cells are preferentially involved in the cytotoxic response in regressing lesions. Forty-two cases were selected: nevi with regression, nonregressing melanoma with brisk inflammation, and regressing melanoma. Sections were stained with hematoxylin and eosin and immunostained for CD8, CD56, and T-cell intracytoplasmic antigen 1. Numbers of total lymphocytes, CD8-positive lymphocytes, and T-cell intracytoplasmic antigen 1-positive lymphocytes did not differ among the 3 populations or based on location. CD56 positivity was significantly different among the 3 populations. Regressing melanomas showed the greatest CD56 activity, followed by regressing nevi, whereas inflamed, nonregressing melanomas showed the least. CD56(+) lymphocytes were mostly counted in areas of early regression. The natural killer cell could plausibly play a role in the occurrence of regression as a cytotoxic effector cell or as a mediator of the cytotoxic mechanism.
Copyright © 2011 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21676435     DOI: 10.1016/j.humpath.2011.02.019

Source DB:  PubMed          Journal:  Hum Pathol        ISSN: 0046-8177            Impact factor:   3.466


  19 in total

1.  Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade.

Authors:  Joy Hsu; Jonathan J Hodgins; Malvika Marathe; Chris J Nicolai; Marie-Claude Bourgeois-Daigneault; Troy N Trevino; Camillia S Azimi; Amit K Scheer; Haley E Randolph; Thornton W Thompson; Lily Zhang; Alexandre Iannello; Nikhita Mathur; Karen E Jardine; Georgia A Kirn; John C Bell; Michael W McBurney; David H Raulet; Michele Ardolino
Journal:  J Clin Invest       Date:  2018-09-10       Impact factor: 14.808

Review 2.  Modulation of innate immunity in the tumor microenvironment.

Authors:  Elena Gonzalez-Gugel; Mansi Saxena; Nina Bhardwaj
Journal:  Cancer Immunol Immunother       Date:  2016-06-25       Impact factor: 6.968

Review 3.  Melanoma: oncogenic drivers and the immune system.

Authors:  Niki Karachaliou; Sara Pilotto; Cristina Teixidó; Santiago Viteri; María González-Cao; Aldo Riso; Daniela Morales-Espinosa; Miguel Angel Molina; Imane Chaib; Mariacarmela Santarpia; Eduardo Richardet; Emilio Bria; Rafael Rosell
Journal:  Ann Transl Med       Date:  2015-10

4.  NK cells sense tumors, course of disease and treatments: Consequences for NK-based therapies.

Authors:  Giulia Fregni; Aurélie Perier; Marie-Françoise Avril; Anne Caignard
Journal:  Oncoimmunology       Date:  2012-01-01       Impact factor: 8.110

5.  Highly effective NK cells are associated with good prognosis in patients with metastatic prostate cancer.

Authors:  Christine Pasero; Gwenaëlle Gravis; Samuel Granjeaud; Mathilde Guerin; Jeanne Thomassin-Piana; Palma Rocchi; Naji Salem; Jochen Walz; Alessandro Moretta; Daniel Olive
Journal:  Oncotarget       Date:  2015-06-10

6.  Phenotypic and functional characteristics of blood natural killer cells from melanoma patients at different clinical stages.

Authors:  Giulia Fregni; Meriem Messaoudene; Emmanuelle Fourmentraux-Neves; Sarra Mazouz-Dorval; Johan Chanal; Eve Maubec; Eduardo Marinho; Isabelle Scheer-Senyarich; Isabelle Cremer; Marie-Françoise Avril; Anne Caignard
Journal:  PLoS One       Date:  2013-10-18       Impact factor: 3.240

7.  Correlation between High Endothelial Vessels and Histopathological Features of Different Pigmented Lesions.

Authors:  Gabriela Avram; F Mixich; M Ioana; V Patrascu; C Monteagudo
Journal:  Curr Health Sci J       Date:  2013-12-29

Review 8.  Natural killer cells as helper cells in dendritic cell cancer vaccines.

Authors:  María Betina Pampena; Estrella Mariel Levy
Journal:  Front Immunol       Date:  2015-01-28       Impact factor: 7.561

9.  Patient's Natural Killer Cells in the Era of Targeted Therapies: Role for Tumor Killers.

Authors:  Meriem Messaoudene; Alexandra Frazao; Pierre Jean Gavlovsky; Antoine Toubert; Nicolas Dulphy; Anne Caignard
Journal:  Front Immunol       Date:  2017-06-12       Impact factor: 7.561

Review 10.  Natural Killer Cell Recognition of Melanoma: New Clues for a More Effective Immunotherapy.

Authors:  Raquel Tarazona; Esther Duran; Rafael Solana
Journal:  Front Immunol       Date:  2016-01-07       Impact factor: 7.561

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.